Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEDIPASVIR\SOFOSBUVIR Cause Atrial fibrillation? 95 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 95 reports of Atrial fibrillation have been filed in association with LEDIPASVIR\SOFOSBUVIR. This represents 0.4% of all adverse event reports for LEDIPASVIR\SOFOSBUVIR.

95
Reports of Atrial fibrillation with LEDIPASVIR\SOFOSBUVIR
0.4%
of all LEDIPASVIR\SOFOSBUVIR reports
14
Deaths
53
Hospitalizations

How Dangerous Is Atrial fibrillation From LEDIPASVIR\SOFOSBUVIR?

Of the 95 reports, 14 (14.7%) resulted in death, 53 (55.8%) required hospitalization, and 10 (10.5%) were considered life-threatening.

Is Atrial fibrillation Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEDIPASVIR\SOFOSBUVIR. However, 95 reports have been filed with the FAERS database.

What Other Side Effects Does LEDIPASVIR\SOFOSBUVIR Cause?

Fatigue (4,609) Headache (4,203) Nausea (1,471) Drug ineffective (1,397) Hepatitis c (1,076) Diarrhoea (1,065) Insomnia (1,021) Hepatocellular carcinoma (640) Vomiting (623) Dizziness (604)

What Other Drugs Cause Atrial fibrillation?

APIXABAN (5,690) IBRUTINIB (3,671) LENALIDOMIDE (2,704) RITUXIMAB (2,100) SACUBITRIL\VALSARTAN (2,062) RIVAROXABAN (2,027) ADALIMUMAB (1,709) METOPROLOL (1,462) DEXAMETHASONE (1,461) METHOTREXATE (1,411)

Which LEDIPASVIR\SOFOSBUVIR Alternatives Have Lower Atrial fibrillation Risk?

LEDIPASVIR\SOFOSBUVIR vs LEFLUNOMIDE LEDIPASVIR\SOFOSBUVIR vs LEMBOREXANT LEDIPASVIR\SOFOSBUVIR vs LENACAPAVIR LEDIPASVIR\SOFOSBUVIR vs LENALIDOMIDE LEDIPASVIR\SOFOSBUVIR vs LENIOLISIB

Related Pages

LEDIPASVIR\SOFOSBUVIR Full Profile All Atrial fibrillation Reports All Drugs Causing Atrial fibrillation LEDIPASVIR\SOFOSBUVIR Demographics